EGFR and cancer: The results indicated that cytosolic DNA-sensing pathway, cell cycle, NOD-like receptor signaling pathway, pathways in cancer, ErbB signaling pathway, and VEGF signaling pathway were activated by the high-risk group of the PRGs prognostic signature (NOM p-val < 0.05 and | NES |> 1; Fig. 7).